Pivotal Bio Venture Partners Investment Advisor LLC Portfolio Holdings
Pivotal Bio Venture Partners Investment Advisor LLC
- $111 Million
- Q3 2025
Pivotal Bio Venture Partners Investment Advisor LLC has filed its 13F form on November 13, 2025 for Q3 2025 where it was disclosed a total value porftolio of $111 Million distributed in 10 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Vaxcyte, Inc. with a value of $49.4M, Arcutis Biotherapeutics, Inc. with a value of $40M, Trevi Therapeutics, Inc. with a value of $11.2M, Immunome Inc. with a value of $5.82M, and Recursion Pharmaceuticals, Inc. with a value of $2.91M.
Examining the 13F form we can see an increase of $4.8M in the current position value, from $106M to 111M.
Pivotal Bio Venture Partners Investment Advisor LLC is based out at San Francisco, CA
Below you can find more details about Pivotal Bio Venture Partners Investment Advisor LLC portfolio as well as his latest detailed transactions.